News for Castle Biosciences, Inc. (CSTL)

Study results show that DecisionDx-Melanoma was associated with a 32% reduction in mortality risk compared to untested patients FRIENDSWOOD, Texas, May 29, 2

**media[640917]**

On May 21, 2025, Scotiabank analyst Sung Ji Nam reaffirmed the "Sector Outperform" rating for Castle Biosciences (CSTL), maintaining the previous rating, indica

Scotiabank has adjusted its price target for Castle Biosciences (CSTL), reducing it to $40 from a previous $44, though it maintains an Outperform rating. Despit

Castle Biosciences (CSTL) to present at the 2025 Jefferies Global Healthcare Conference on June 4, 2025. Live webcast available on the company's investo

Castle Biosciences (CSTL) has unveiled new findings from an independent validation of the Collaborative Ocular Oncology Group Study No. 2, which were made publi

In recognition of Skin Cancer Awareness Month this May, Castle Biosciences (CSTL) is spearheading a variety of initiatives aimed at enhancing awareness and educ

The Company continues its ongoing partnerships with IMPACT Melanoma, AIM at Melanoma and Melanoma Research Foundation to drive education and awareness throughou

**media[617214]**

Castle Biosciences (CSTL) continues to be a focus of attention following a recent update from Lake Street analyst, Thomas Flaten. The analyst has maintained a "

U.S. stock futures were lower this morning, with the Dow futures falling over 200 points on Tuesday. Shares of Ichor Holdings, Ltd. ICHR fell sharply in today'...

**media[613229]**

Castle Biosciences (CSTL) to release Q1 2025 financial results on May 5, 2025, after market close. A conference call and webcast are scheduled at 4:30 p

FRIENDSWOOD, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. ( CSTL), a company improving health through innovative tests that guide patien

**media[594181]**

**media[588928]**

FRIENDSWOOD, Texas, April 07, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. ( CSTL), a company improving health through innovative tests that guide patien

**media[587694]**

**media[583212]**